eLaws | eCases | United States Code | Federal Courts |

Plasma Protein Therapeutics Association (PPTA) - Comment

Document ID: FDA-2011-D-0799-0003
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 27 2012, at 12:00 AM Eastern Standard Time
Date Posted: February 13 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: November 28 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: January 27 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fa75e2
View Document:

This is comment on Notice

Draft Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components, etc.

View Comment

Please see comment letter attached. Thank you,

Attachments:

Plasma Protein Therapeutics Association (PPTA) FDAA12003_HBV NAT

Title:
Plasma Protein Therapeutics Association (PPTA) FDAA12003_HBV NAT

View Attachment:

View as format pdf

Related Comments

View All

Total: 6

Plasma Protein Therapeutics Association (PPTA) - Comment
Public Submission Posted: 02/13/2012 ID: FDA-2011-D-0799-0003

Comment Period Closed
Jan 27,2012 11:59 PM ET

Roche Molecular Systems, Inc. - Comment
Public Submission Posted: 02/13/2012 ID: FDA-2011-D-0799-0004

Comment Period Closed
Jan 27,2012 11:59 PM ET

America's Blood Centers - Comment
Public Submission Posted: 02/13/2012 ID: FDA-2011-D-0799-0005

Comment Period Closed
Jan 27,2012 11:59 PM ET

Roche Molecular Systems, Inc. (RMS) - Comment
Public Submission Posted: 04/17/2012 ID: FDA-2011-D-0799-0006

Comment Period Closed
Jan 27,2012 11:59 PM ET

Viacord Processing Laboratory (VPL) - Comment
Public Submission Posted: 04/17/2012 ID: FDA-2011-D-0799-0007

Comment Period Closed
Jan 27,2012 11:59 PM ET